Clinical Trial Update: PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of clopidogrel versus placebo on inflammation in people with metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Sanofi | Conditions: Metabolic Syndrome x | Phase 4 | Status: COMPLETED